Correction: Complement inhibitor CSMD1 acts as tumor suppressor in human breast cancer.

Escudero-Esparza, Astrid; Bartoschek, Michael; Gialeli, Chrysostomi; Okroj, Marcin; Owen, Sioned; Jirström, Karin; Orimo, Akira; Jiang, Wen G; Pietras, Kristian; Blom, Anna M

Escudero-Esparza, Astrid; Bartoschek, Michael; Gialeli, Chrysostomi; Okroj, Marcin; Owen, Sioned; Jirström, Karin; Orimo, Akira; Jiang, Wen G; Pietras, Kristian; Blom, Anna M.

Afiliação

Escudero-Esparza A; Department of Translational Medicine, Lund University, Malmö, Sweden.
Bartoschek M; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Gialeli C; Department of Translational Medicine, Lund University, Malmö, Sweden.
Okroj M; Department of Medical Biotechnology, Medical University of Gdansk, Gdansk, Poland.
Owen S; Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
Jirström K; Department of Clinical Sciences, Lund University, Lund, Sweden.
Orimo A; Department of Pathology and Oncology, Juntendo University School of Medicine, Tokyo, Japan.
Jiang WG; Cardiff China Medical Research Collaborative, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
Pietras K; Department of Laboratory Medicine, Lund University, Lund, Sweden.
Blom AM; Department of Translational Medicine, Lund University, Malmö, Sweden.

Oncotarget ; 14: 481-482, 2023 May 19.

Article em En | MEDLINE | ID: mdl-37204255

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Suécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google